Loading...

Industry News

SynBioBeta brings you the latest news in synthetic biology. Have news to share? Contact us to submit your story.

Subscribe

Stay updated on the latest news in synthetic biology

Subscribe to the SynBioBeta news digest
Subscribe

Featured Articles

July 2018

AgBiome LLC Secures Series C Funding

Labcyte to Support GP-write Project Under New Agreement with Center of Excellence for Engineering Biology

Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics

Lygos Raises $15.5 Million to Accelerate Delivery of Clean and Sustainable Biology-Based Performance Materials

Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development

Investment fuels cutting-edge synthetic biology in UK

Inscripta Granted Patents for CRISPR Gene-Editing Systems

Your skin: The new frontier in microbial medicine

Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel Disease

Butanova awarded with commercial evaluation grant

Food 2.0: Three companies that are changing the way we eat

Gene drives accelerate evolution – but we need brakes

DNA Script Awarded $2.7M in Innovation Grants From Bpifrance — Total Financing Raised to Date Is $27M

Penn Announces Publication of Clinically Relevant Genome Editing in Primates Using Precision’s ARCUS Platform

Dr. Craig Behnke Joins Lumen Bioscience as SVP, Production and Development

Evolva announces Oliver Walker to succeed Simon Waddington as CEO

GenScript to launch new platform to save up to a billion USD for worldwide research community

Synthace expands UK presence, relocates to new White City life sciences hub

Codexis Doses First Subjects in Phase 1a Trial of CDX-6114

Latest News

tadalafiltablets findviagra.com http://xanaxonlinebuy.com/